United States

DiaSorin SpA (DIAS.MI)

DIAS.MI on Milan Stock Exchange

11:35am EDT
Change (% chg)

€0.35 (+0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Aug 30 2016

BRIEF-DiaSorin and Beckman Coulter form partnership to bring hepatitis and HIV tests to U.S.

* DiaSorin and Beckman Coulter Diagnostics (Beckman Coulter) form strategic partnership to bring Liaison XL hepatitis and HIV products to the United States market

BRIEF-DiaSorin Q2 net profit up 12.0 pct to EUR 29.4 mln

* Q2 net profit 29.4 million euros ($32.73 million), up 12.0 percent year on year

BRIEF-DiaSorin launches test Iam AML1-ETO for screening of acute myeloid leukemia

* Launches Iam AML1-ETO, a test for the molecular screening of acute myeloid leukemia

BRIEF-Diasorin launches new test for IgG to Helicobacter Pylori detection

* Says launched the new LIAISON test for qualitative detection of IgG to Helicobacter Pylori in human serum Source text for Eikon:

BRIEF-DiaSorin Q1 net profit rises to EUR 24.7 mln

* Q1 revenue 124.5 million euros ($141.69 million) versus 117.6 million euros a year ago

Select another date: